Decreasing trends in cholangiocarcinoma incidence and relative survival in Khon Kaen, Thailand: An updated, inclusive, population-based cancer registry analysis for 1989-2018
- PMID: 33592053
- PMCID: PMC7886206
- DOI: 10.1371/journal.pone.0246490
Decreasing trends in cholangiocarcinoma incidence and relative survival in Khon Kaen, Thailand: An updated, inclusive, population-based cancer registry analysis for 1989-2018
Abstract
Background: Cholangiocarcinoma (CCA) is a leading cause of cancer death in northeastern Thailand. We reported on the incidence of CCA using only one method. In the current study, we used three different statistical methods to forecast future trends and estimate relative survival.
Methods: We reviewed the CCA cases diagnosed between 1989 and 2018 recorded in the population-based Khon Kaen Cancer Registry (KKCR). Annual percent change (APC) was calculated to quantify the incidence rate trends using Joinpoint regression. Age-period-cohort models (APC model) were used to examine the temporal trends of CCA by age, calendar year, and birth cohort. We projected the incidence of CCA up to 2028 using three independent approaches: the Joinpoint, Age-period-cohort, and Nordpred models. Survival assessments were based on relative survival (RS).
Results: The respective APC in males and females decreased significantly (-3.1%; 95%CI: -4.0 to -2.1 and -2.4%; 95%CI: -3.6 to -1.2). The APC model-AC-P for male CCA-decreased according to a birth-cohort. The CCA incidence for males born in 1998 was 0.09 times higher than for those born in 1966 (Incidence rate ratios, IRR = 0.09; 95%CI: 0.07 to 0.12). The relative incidence for female CCA similarly decreased according to a birth-cohort (IRR = 0.11; 95%CI: 0.07 to 0.17). The respective projection for the age-standardized rate for males and females for 2028 will be 7.6 per 100,000 (102 patients) and 3.6 per 100,000 (140 patients). The five-year RS for CCA was 10.9% (95%CI: 10.3 to 11.6).
Conclusion: The incidence rate of CCA has decreased. The projection for 2028 is that the incidence will continue to decline. Nevertheless, the survival of patients with CCA remains poor.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures




Similar articles
-
Cholangiocarcinoma Trends, Incidence, and Relative Survival in Khon Kaen, Thailand From 1989 Through 2013: A Population-Based Cancer Registry Study.J Epidemiol. 2019 May 5;29(5):197-204. doi: 10.2188/jea.JE20180007. Epub 2018 Aug 4. J Epidemiol. 2019. PMID: 30078813 Free PMC article.
-
Trends in liver cancer incidence between 1985 and 2009, Khon Kaen, Thailand: cholangiocarcinoma.Asian Pac J Cancer Prev. 2011;12(9):2209-13. Asian Pac J Cancer Prev. 2011. PMID: 22296358
-
Temporal Trends and Geographic Patterns of Lung Cancer Incidence by Histology in Thailand, 1990 to 2014.J Glob Oncol. 2018 Aug;4:1-29. doi: 10.1200/JGO.18.00013. J Glob Oncol. 2018. PMID: 30192698 Free PMC article.
-
Roles of liver fluke infection as risk factor for cholangiocarcinoma.J Hepatobiliary Pancreat Sci. 2014 May;21(5):301-8. doi: 10.1002/jhbp.62. Epub 2014 Jan 10. J Hepatobiliary Pancreat Sci. 2014. PMID: 24408775 Review.
-
Surgical management of perihilar cholangiocarcinoma: a Khon Kaen experience.J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):521-4. doi: 10.1002/jhbp.74. Epub 2014 Jan 27. J Hepatobiliary Pancreat Sci. 2014. PMID: 24464976 Review.
Cited by
-
Overexpression of microRNA-205-5p promotes cholangiocarcinoma growth by reducing expression of homeodomain-interacting protein kinase 3.Sci Rep. 2023 Dec 17;13(1):22444. doi: 10.1038/s41598-023-49694-x. Sci Rep. 2023. PMID: 38105269 Free PMC article.
-
Validation of the Thai Version of the Memorial Symptom Assessment Scaled - Short Form Among Cholangiocarcinoma Patients.Asian Pac J Cancer Prev. 2022 Nov 1;23(11):3851-3857. doi: 10.31557/APJCP.2022.23.11.3851. Asian Pac J Cancer Prev. 2022. PMID: 36444598 Free PMC article.
-
The Epidemiology of Biliary Tract Cancer and Associated Prevalence of MDM2 Amplification: A Targeted Literature Review.Target Oncol. 2024 Nov;19(6):833-844. doi: 10.1007/s11523-024-01086-5. Epub 2024 Sep 20. Target Oncol. 2024. PMID: 39302603 Free PMC article. Review.
-
β-Eudesmol Inhibits the Migration of Cholangiocarcinoma Cells by Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT and p38MAPK Modulation.Asian Pac J Cancer Prev. 2022 Aug 1;23(8):2573-2581. doi: 10.31557/APJCP.2022.23.8.2573. Asian Pac J Cancer Prev. 2022. PMID: 36037109 Free PMC article.
-
Spatial analysis of cholangiocarcinoma in Thailand from 2012 to 2021; a population-based cancer registries study.PLoS One. 2024 Dec 11;19(12):e0311035. doi: 10.1371/journal.pone.0311035. eCollection 2024. PLoS One. 2024. PMID: 39661606 Free PMC article.
References
-
- Globocan 2020. 2018 Oct 17 [cited 20 Dec 2020]. In: Global Cancer Observatory [Internet]. France. http://globocan.iarc.fr.
-
- London WT, McGlynn KA. Liver cancer In: Schottenfeld D, Fraumeni J Jr, eds. Cancer Epidemiology and Prevention. 3rd ed New York: Oxford University Press; 2006.
-
- Vatanasapt V, Tangvoraphonkchai V, Titapant V, Pipitgool V, Viriyapap D, Sriamporn S. A high incidence of liver cancer in Khon Kaen Province, Thailand. Southeast Asian J Trop Med Public Health. 1990;21:489–94. . - PubMed
-
- Green A, Uttaravichien T, Bhudhisawasdi V, Chartbanchachai W, Elkins DB, Marieng EO, et al. Cholangiocarcinoma in northeast Thailand. A hospital-based study. Trop Geogr Med. 1991;43:193–8. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources